51 result(s) for 'Lung'
1 - 10 of 51 results for 'Lung'
Sort by
Show
In this webinar, Dr. Keith Wharton reviews a set of published studies using single cell analysis of lung tissues that have provided ground breaking insight into lung development and disease.
Antigen Background
34E12 reacts with human cytokeratin intermediate filament proteins 1, 5, 10 and 14. The antibody is reported to react with squamous epithelium and sweat ducts in normal skin, some pneumocytes, bronchial epithelium and mesothelium in normal lung and bile ducts in normal liver. It also reacts with ductal cells of the normal pancreas, some acinar and ductal cells of normal breast, some follicular epithelia of normal thyroid and so...
Antigen BackgroundMuc-4 (Mucin 4) is an O-glycoprotein that consists of a large extracellular glycosylated subunit, transmembrane domain and intracellular domain. MUC4 is known to play a protective role for cell membrane and has anti-adhesive properties. It is understood to play a role in cancer progression, facilitating tumour progression via apoptosis inhibition. MUC4 is aberrantly expressed in several cancers including those of the bile duct, ...
Translocations of the ALK (anaplastic lymphoma kinase) gene at 2p23 have originally been associated with anaplastic lymphomas, B-cell lymphomas, neuroblastomas and myofibroblastic tumors. At least 21 translocation partners have been described, however 80% of the translocations involves the NPM1 gene (5q35). ALK rearrangements have been described in non-small cell lung cancer (NSCLC) cases. The ALK (2p23) Break probe is optimized to detect translo...
Pericentric inversion of chromosome 10 involving the RET (ret proto-oncogene) gene at chromosome 10q11 is known to increase expression of the RET gene by fusion with KIF5B (10p11). Translocations with other fusion partners have also been described. Elevated expression of RET is observed in non-small cell lung cancer (NSCLC). Translocations involving RET have also been described in thyroid carcinomas. The RET (10q11) Break probe is optimized to de...
Amplification of the fibroblast growth factor receptor type 1 gene (FGFR1) has been observed in numerous cancer types including lung cancer (especially squamous cell carcinoma) and breast cancer. The FGFR1 (8p11)/SE 8 FISH probe is optimized to detect amplification involving the FGFR1 gene region at 8p11 in a dual-color assay on paraffin embedded tissue sections. The chromosome 8 satellite enumeration probe (SE 8) at D8Z1 is included to facilitat...
Amplification of the 3q26-q27 has a high prevalence in cervical, prostate, lung, and squamous cell carcinoma. This amplification can also be found to a lesser extent in CLL patients. The minimal region of amplification was refined to a 1- to 2-Mb genomic segment containing several potential cancer genes including TERC, the human telomerase RNA gene. The TERC (3q26) specific FISH probe is optimized to detect copy numbers of the TERC (previously kn...
Pericentric inversion of chromosome 10 involving the RET (ret proto-oncogene) gene at chromosome 10q11 is known to increase expression of the RET gene by fusion with KIF5B (10p11). Translocations with other fusion partners have also been described. Elevated expression of RET is observed in non-small cell lung cancer (NSCLC), in which the function of tyrosine kinase-based therapeutics is based on the inhibition of such fusion proteins. Translocati...
Translocations of the ALK (anaplastic lymphoma kinase) gene at 2p23 have originally been associated with anaplastic lymphomas, B-cell lymphomas, neuroblastomas and myofibroblastic tumors. At least 21 translocation partners have been described, however 80% of the translocations involves the NPM1 gene (5q35). ALK rearrangements have been described in non-small cell lung cancer (NSCLC) cases. Multiple tyrosine kinsae inhibitors (TKI's) specific for ...
The inversion in 2p21 and 2p23 leading to a fusion of the kinase domain of ALK (anaplastic lymphoma kinase) and EML4 (echinoderm microtubule associated protein like 4) has been described in 5-7% of non-small cell lung cancer (NSCLC) cases. The ALK/EML4 t(2;2); inv(2) Fusion probe is designed as a dual-color assay to detect the fusion of the ALK gene with the EML4 gene by paracentric inversion with breakage and reunion occurring at bands 2p21 and ...